Connecting environmental exposure and neurodegeneration using cheminformatics and high resolution mass spectrometry: potential and challenges

Connecting chemical exposures over a lifetime to complex chronic diseases with multifactorial causes such as neurodegenerative diseases is an immense challenge requiring a long-term, interdisciplinary approach. Rapid developments in analytical and data technologies, such as non-target high resolutio...

Full description

Saved in:
Bibliographic Details
Published inEnvironmental science--processes & impacts Vol. 21; no. 9; pp. 1426 - 1445
Main Authors Schymanski, Emma L, Baker, Nancy C, Williams, Antony J, Singh, Randolph R, Trezzi, Jean-Pierre, Wilmes, Paul, Kolber, Pierre L, Kruger, Rejko, Paczia, Nicole, Linster, Carole L, Balling, Rudi
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 18.09.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Connecting chemical exposures over a lifetime to complex chronic diseases with multifactorial causes such as neurodegenerative diseases is an immense challenge requiring a long-term, interdisciplinary approach. Rapid developments in analytical and data technologies, such as non-target high resolution mass spectrometry (NT-HR-MS), have opened up new possibilities to accomplish this, inconceivable 20 years ago. While NT-HR-MS is being applied to increasingly complex research questions, there are still many unidentified chemicals and uncertainties in linking exposures to human health outcomes and environmental impacts. In this perspective, we explore the possibilities and challenges involved in using cheminformatics and NT-HR-MS to answer complex questions that cross many scientific disciplines, taking the identification of potential (small molecule) neurotoxicants in environmental or biological matrices as a case study. We explore capturing literature knowledge and patient exposure information in a form amenable to high-throughput data mining, and the related cheminformatic challenges. We then briefly cover which sample matrices are available, which method(s) could potentially be used to detect these chemicals in various matrices and what remains beyond the reach of NT-HR-MS. We touch on the potential for biological validation systems to contribute to mechanistic understanding of observations and explore which sampling and data archiving strategies may be required to form an accurate, sustained picture of small molecule signatures on extensive cohorts of patients with chronic neurodegenerative disorders. Finally, we reflect on how NT-HR-MS can support unravelling the contribution of the environment to complex diseases. A multi-disciplinary perspective on connecting chemistry, exposure and medical information to "neurotoxicity" for mass spectrometry-based environmental assessment, including multiple interactive resources for readers to use and explore.
Bibliography:Associate Professor Emma Schymanski is a Luxembourg National Research Fund (FNR) ATTRACT Fellow and head of the Environmental Cheminformatics group at the Luxembourg Centre for Systems Biomedicine (LSCB), University of Luxembourg. Dr Randolph Singh is a postdoctoral fellow in the same group. Dr Nancy Baker is a consultant at Leidos, Research Triangle Park, USA. Dr Antony Williams is a Computational Chemist, National Center of Computational Toxicology, US EPA. Dr Jean-Pierre Trezzi is postdoctoral fellow affiliated with the Integrated Biobank of Luxembourg, Luxembourg Institute of Health as well as the Eco-Systems Biology group at LCSB, which is headed by Associate Professor Paul Wilmes. Dr med. Pierre Kolber, MD is a member of Neurology department at the Centre Hospitalier de Luxembourg and the Clinical and Experimental Neuroscience Group at LCSB, which is headed by Professor Dr med. Rejko Krüger, also an FNR PEARL Fellow and Director of Transversal Translational Medicine at the Luxembourg Institute of Health. Dr Nicole Paczia, former joint-manager of the Metabolomics Platform at LCSB, now heads the Metabolomics Core facility at the Max Planck Institute in Marburg. Dr Carole Linster is head of the Enzymology and Metabolism Group, LCSB. Professor Rudi Balling is Director of the LCSB.
Electronic supplementary information (ESI) available. See DOI
10.1039/c9em00068b
ISSN:2050-7887
2050-7895
DOI:10.1039/c9em00068b